Skip to main content
. 2020 May 20;7(4):1605–1614. doi: 10.1002/ehf2.12712

Figure 2.

Figure 2

(A) Kaplan–Meier event‐free survival curves for occurrence of major adverse clinical events in patients with (red) and without (blue) left ventricular hypertrophy. (B) Kaplan–Meier event‐free survival curves for occurrence of major adverse clinical events in patients with (red) and without (blue) high proteinuria levels.